|

CYP2C19 Genotype Guided DAPT Clinical Trials

1 actively recruiting trial

Also known as: Guided DAPT

Pipeline

Phase 4: 1

Top Sponsors

  • Zunyi Medical College1

Indications

  • CYP2C19 Polymorphism1
  • ACS - Acute Coronary Syndrome1
  • Heart Disease1

Other1 trial

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.